Clinical Application of Targeted Deep Sequencing in Solid‐Cancer Patients and Utility for Biomarker‐Selected Clinical Trials

Molecular profiling of actionable mutations in refractory cancer patients has the potential to enable “precision medicine,” wherein individualized therapies are guided based on genomic profiling. The molecular‐screening program was intended to route participants to different candidate drugs in trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kim, Seung Tae, Kim, Kyoung‐Mee, Kim, Nayoung K.D., Park, Joon Oh, Ahn, Soomin, Yun, Jae‐Won, Kim, Kyu‐Tae, Park, Se Hoon, Park, Peter J., Kim, Hee Cheol, Sohn, Tae Sung, Choi, Dong Il, Cho, Jong Ho, Heo, Jin Seok, Kwon, Wooil, Lee, Hyuk, Min, Byung‐Hoon, Hong, Sung No, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Park, Woong‐Yang, Lee, Jeeyun
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Cancer Diagnostics and Molecular Pathology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634774/
https://ncbi.nlm.nih.gov/pubmed/28701572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados